Dieser Download kann aus rechtlichen Gründen nur mit Rechnungsadresse in A, B, BG, CY, CZ, D, DK, EW, E, FIN, F, GR, HR, H, IRL, I, LT, L, LR, M, NL, PL, P, R, S, SLO, SK ausgeliefert werden.
Herstellerkennzeichnung
Die Herstellerinformationen sind derzeit nicht verfügbar.
Inhaltsangabe
Solved and Unsolved Problems in Heart Valve Replacement.- The St. Jude Medical Prosthetic Heart Valve: Results from a Five-Year Multicenter Experience.- Choosing Between Mechanical and Tissue Valves for the Treatment of Valvular Heart Disease.- Preferred Use of Allografts in the Treatment of Valvular Heart Disease.- The Use of Mechanical Valves in the Treatment of Valvular Heart Disease.- The Choice Between Valve Preservation and Valve Replacement.- The Limits of Central Hemodynamic Improvement by Heart Valve Replacement.- Can the Hemodynamics of Prosthetic Heart Valves be Evaluated Sufficiently by In Vitro Tests?.- Is the Late Outcome of Heart Valve Replacement Influenced by the Hemodynamics of the Heart Valve Substitute?.- When are Hemodynamics Important for the Selection of a Prosthetic Heart Valve?.- Prosthetic Valve-related or Valve-induced Complications.- Non-invasive Follow-up of Prosthetic Heart Valves.- Hemolysis Following Cardiac Valve Replacement.- The Risk of Thromboembolism and Hemorrhage After Implantation of Heart Valve Prostheses.- Anticoagulation and Prosthetic Heart Valves.- Valve Malfunction and Heart Valve Replacement in Patients at Risk.- Incidence, Clinical Findings and Management of Prosthetic Valve Malfunction.- Valve Replacement in Children with Congenital Heart Disease.- Valve Replacement in Infancy and Childhood.
Solved and Unsolved Problems in Heart Valve Replacement.- The St. Jude Medical Prosthetic Heart Valve: Results from a Five-Year Multicenter Experience.- Choosing Between Mechanical and Tissue Valves for the Treatment of Valvular Heart Disease.- Preferred Use of Allografts in the Treatment of Valvular Heart Disease.- The Use of Mechanical Valves in the Treatment of Valvular Heart Disease.- The Choice Between Valve Preservation and Valve Replacement.- The Limits of Central Hemodynamic Improvement by Heart Valve Replacement.- Can the Hemodynamics of Prosthetic Heart Valves be Evaluated Sufficiently by In Vitro Tests?.- Is the Late Outcome of Heart Valve Replacement Influenced by the Hemodynamics of the Heart Valve Substitute?.- When are Hemodynamics Important for the Selection of a Prosthetic Heart Valve?.- Prosthetic Valve-related or Valve-induced Complications.- Non-invasive Follow-up of Prosthetic Heart Valves.- Hemolysis Following Cardiac Valve Replacement.- The Risk of Thromboembolism and Hemorrhage After Implantation of Heart Valve Prostheses.- Anticoagulation and Prosthetic Heart Valves.- Valve Malfunction and Heart Valve Replacement in Patients at Risk.- Incidence, Clinical Findings and Management of Prosthetic Valve Malfunction.- Valve Replacement in Children with Congenital Heart Disease.- Valve Replacement in Infancy and Childhood.
Es gelten unsere Allgemeinen Geschäftsbedingungen: www.buecher.de/agb
Impressum
www.buecher.de ist ein Internetauftritt der buecher.de internetstores GmbH
Geschäftsführung: Monica Sawhney | Roland Kölbl | Günter Hilger
Sitz der Gesellschaft: Batheyer Straße 115 - 117, 58099 Hagen
Postanschrift: Bürgermeister-Wegele-Str. 12, 86167 Augsburg
Amtsgericht Hagen HRB 13257
Steuernummer: 321/5800/1497
USt-IdNr: DE450055826
